NCT00265993 - Enoxaparin in Acute Venous Thromboembolic Disease | Biotech Hunter

Enrollment

251

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions

Venous Thrombosis

Interventions

DRUG

enoxaparin

"* All patients will be treated with enoxaparin 1.5 mg/kg, once a day, subcutaneously for up to 10 days.~* Long-term oral anticoagulation will be started in all patients after 24 hours of initiation of enoxaparin treatment and continued at least for 3 months."

Trial Locations (1)

Unknown

Sanofi-Aventis Administrative Office, Istanbul